Human HSCs Transdifferentiated from MSCs can be Used for the Treatment of Blood Diseases and Fabrication of BloodThursday, 28 June 2012 at 09:30 Add to Calendar ▼2012-06-28 09:30:002012-06-28 10:30:00Europe/LondonHuman HSCs Transdifferentiated from MSCs can be Used for the Treatment of Blood Diseases and Fabrication of BloodSELECTBIOenquiries@selectbiosciences.com Our findings provide the first demonstration that transfection of two small RNAs (sRNA) for two days is sufficient to trigger adipose-derived mesenchymal stem cells (AD-MSCs) to transdifferentiate into hematopoietic stem cells (HSCs) in a large-scale level. |